Matthew P. Gray

842 total citations
32 papers, 432 citations indexed

About

Matthew P. Gray is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Toxicology. According to data from OpenAlex, Matthew P. Gray has authored 32 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 7 papers in Toxicology. Recurrent topics in Matthew P. Gray's work include Pharmacovigilance and Adverse Drug Reactions (7 papers), Emergency and Acute Care Studies (5 papers) and Respiratory and Cough-Related Research (4 papers). Matthew P. Gray is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (7 papers), Emergency and Acute Care Studies (5 papers) and Respiratory and Cough-Related Research (4 papers). Matthew P. Gray collaborates with scholars based in United States, United Kingdom and Canada. Matthew P. Gray's co-authors include Brian A. Link, Simon W. M. John, Sandra L. Kane‐Gill, Richard S. Smith, Sonal S. Tuli, Amy L. Drendel, E. Brooke Lerner, Richard D. Boyce, Ronald G. Gregg and Jason R. Willer and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and PLoS Genetics.

In The Last Decade

Matthew P. Gray

30 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew P. Gray United States 13 114 82 80 63 60 32 432
Markus Große Perdekamp Germany 9 40 0.4× 93 1.1× 63 0.8× 43 0.7× 11 0.2× 23 282
Richard McNulty Australia 9 162 1.4× 44 0.5× 77 1.0× 34 0.5× 16 0.3× 18 491
Younghwan Kim South Korea 12 68 0.6× 10 0.1× 83 1.0× 15 0.2× 12 0.2× 48 395
G Rizzo Italy 12 59 0.5× 30 0.4× 14 0.2× 34 0.5× 17 0.3× 38 527
Ying Dai China 10 67 0.6× 99 1.2× 55 0.7× 88 1.4× 5 0.1× 20 339
Stuart Baker Australia 12 169 1.5× 7 0.1× 27 0.3× 64 1.0× 11 0.2× 27 583
Xiao Ding China 11 29 0.3× 51 0.6× 107 1.3× 42 0.7× 1 0.0× 24 509
Ciorsti MacIntyre Canada 12 139 1.2× 13 0.2× 13 0.2× 15 0.2× 13 0.2× 37 621
George K. Asdourian United States 14 205 1.8× 111 1.4× 17 0.2× 64 1.0× 11 0.2× 20 749
Haohua Deng China 10 78 0.7× 17 0.2× 8 0.1× 27 0.4× 8 0.1× 15 570

Countries citing papers authored by Matthew P. Gray

Since Specialization
Citations

This map shows the geographic impact of Matthew P. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew P. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew P. Gray more than expected).

Fields of papers citing papers by Matthew P. Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew P. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew P. Gray. The network helps show where Matthew P. Gray may publish in the future.

Co-authorship network of co-authors of Matthew P. Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew P. Gray. A scholar is included among the top collaborators of Matthew P. Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew P. Gray. Matthew P. Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gray, Matthew P., John A. Kellum, Levent Kirisci, Richard D. Boyce, & Sandra L. Kane‐Gill. (2024). Long-Term Outcomes Associated With β-Lactam Allergies. JAMA Network Open. 7(5). e2412313–e2412313. 2 indexed citations
3.
Gray, Matthew P., et al.. (2023). Qualitative analysis of healthcare provider perspectives to evaluating beta-lactam allergies. Journal of Hospital Infection. 141. 198–208. 4 indexed citations
4.
McDermott, Michael C., et al.. (2023). Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study. Therapeutic Advances in Drug Safety. 14. 1581633558–1581633558. 14 indexed citations
5.
Gray, Matthew P., Erin F. Barreto, John A. Kellum, et al.. (2022). Consensus Obtained for the Nephrotoxic Potential of 167 Drugs in Adult Critically Ill Patients Using a Modified Delphi Method. Drug Safety. 45(4). 389–398. 22 indexed citations
6.
Kim, Hyunwoo, et al.. (2021). Assessing Adverse Drug Reactions Reported for New Respiratory Medications in the FDA Adverse Event Reporting System Database. Respiratory Care. 66(11). 1739–1745. 2 indexed citations
7.
8.
Gray, Matthew P., et al.. (2021). Stroke or No Stroke: A Case Report of Bilingual Aphasia. SHILAP Revista de lepidopterología. 5(3). 325–327.
9.
Gray, Matthew P., Alvaro San-Juan-Rodriguez, Nemin Chen, Chester B. Good, & Inmaculada Hernandez. (2019). Impact of direct-to-consumer drug advertising during the Super Bowl on drug utilization. Research in Social and Administrative Pharmacy. 16(8). 1136–1139. 2 indexed citations
10.
Gray, Matthew P., et al.. (2019). Improving Emergency Department Management of Diabetic Ketoacidosis in Children. PEDIATRICS. 144(4). 9 indexed citations
11.
Gray, Matthew P., et al.. (2018). Assessing Adverse Drug Reactions from Psychotropic Medications Reported to the U.S. Food and Drug Administration in Older Adults. American Journal of Geriatric Psychiatry. 27(2). 181–185. 4 indexed citations
12.
Tuli, Sonal S., et al.. (2018). Surgical management of herpetic keratitis. Current Opinion in Ophthalmology. 29(4). 347–354. 18 indexed citations
13.
Sale, Joanna E. M., Matthew P. Gray, Taucha Inrig, et al.. (2018). Treatment recommendations based on fracture risk status are not consistently provided in osteoporosis guidelines. Rheumatology International. 38(12). 2193–2208. 1 indexed citations
14.
Ferguson, Catherine, et al.. (2017). Reducing Unnecessary Imaging for Patients With Constipation in the Pediatric Emergency Department. PEDIATRICS. 140(1). 20 indexed citations
15.
Tuli, Sonal S. & Matthew P. Gray. (2016). Surgical management of corneal infections. Current Opinion in Ophthalmology. 27(4). 340–347. 20 indexed citations
16.
Lerner, E. Brooke, Amy L. Drendel, Richard A. Falcone, et al.. (2015). A consensus-based criterion standard definition for pediatric patients who needed the highest-level trauma team activation. The Journal of Trauma: Injury, Infection, and Critical Care. 78(3). 634–638. 33 indexed citations
17.
Willer, Jason R., Ross F. Collery, Matthew P. Gray, et al.. (2011). Mutations in Zebrafish lrp2 Result in Adult-Onset Ocular Pathogenesis That Models Myopia and Other Risk Factors for Glaucoma. PLoS Genetics. 7(2). e1001310–e1001310. 79 indexed citations
18.
Gray, Matthew P., et al.. (2007). Zebrafish With the brass Mutation Show Glaucoma-Associated Phenotypes. Investigative Ophthalmology & Visual Science. 48(13). 5917–5917. 1 indexed citations
19.
Link, Brian A., Matthew P. Gray, Richard S. Smith, & Simon W. M. John. (2004). Intraocular Pressure in Zebrafish: Comparison of Inbred Strains and Identification of a Reduced Melanin Mutant with Raised IOP. Investigative Ophthalmology & Visual Science. 45(12). 4415–4415. 44 indexed citations
20.
John, Simon W. M., Richard S. Smith, Brian D. Perkins, et al.. (2003). Characterization of the Zebrafish bug eye Mutation, Exploring a Genetic Model for Pressure-induced Retinal Cell Death. Investigative Ophthalmology & Visual Science. 44(13). 1125–1125. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Große Perdekamp Breakdown of academic impact, for papers by Richard McNulty Breakdown of academic impact, for papers by Younghwan Kim Breakdown of academic impact, for papers by G Rizzo Breakdown of academic impact, for papers by Ying Dai Breakdown of academic impact, for papers by Stuart Baker Breakdown of academic impact, for papers by Xiao Ding Breakdown of academic impact, for papers by Ciorsti MacIntyre Breakdown of academic impact, for papers by George K. Asdourian Breakdown of academic impact, for papers by Haohua Deng
Rankless by CCL
2026